Literature DB >> 27117490

Pyridine Based Antitumour Compounds Acting at the Colchicine Site.

R Álvarez, L Aramburu, P Puebla, E Caballero, M González, A Vicente, M Medarde, R Peláez1.   

Abstract

Antimitotics binding at the colchicine site of tubulin are important antitumour and vascular disrupting agents. Pyridines and azines are privileged scaffolds in medicinal chemistry and in recent years many colchicine site ligands (CSL) have incorporated them into their structures with the aim of improving their pharmacokinetic and pharmacodynamics properties. CSL have been classified according to their chemical structures and the chemical structures of the pyridine and azine containing antimitotic compounds are described. The designed principles behind the structural modifications and the achieved effect on the biological activity upon inclusion of these heterocycles are also discussed. Lessons from the achievements and failures have been extracted and future perspectives delineated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27117490     DOI: 10.2174/092986732311160420104823

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  7 in total

1.  Structure Dependence of Pyridine and Benzene Derivatives on Interactions with Model Membranes.

Authors:  Benjamin J Peters; Cameron Van Cleave; Allison A Haase; John Peter B Hough; Keisha A Giffen-Kent; Gabriel M Cardiff; Audra G Sostarecz; Dean C Crick; Debbie C Crans
Journal:  Langmuir       Date:  2018-07-19       Impact factor: 3.882

2.  Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line.

Authors:  Myriam González; María Ovejero-Sánchez; Alba Vicente-Blázquez; Manuel Medarde; Rogelio González-Sarmiento; Rafael Peláez
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 3.  Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review.

Authors:  Mamdouh F A Mohamed; Gamal El-Din A Abuo-Rahma
Journal:  RSC Adv       Date:  2020-08-21       Impact factor: 4.036

4.  The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors.

Authors:  Myriam González; Younes Ellahioui; Raquel Álvarez; Laura Gallego-Yerga; Esther Caballero; Alba Vicente-Blázquez; Laura Ramudo; Miguel Marín; Cristina Sanz; Manuel Medarde; Rafael Pelaéz
Journal:  Molecules       Date:  2019-11-26       Impact factor: 4.411

Review 5.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162

Review 6.  Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy.

Authors:  Yun Liu; Yang Li; Yuxi Wang; Congcong Lin; Dan Zhang; Juncheng Chen; Liang Ouyang; Fengbo Wu; Jifa Zhang; Lei Chen
Journal:  J Hematol Oncol       Date:  2022-07-07       Impact factor: 23.168

7.  Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors.

Authors:  Shanbo Yang; Chao Wang; Lingyu Shi; Jing Chang; Yujing Zhang; Jingsen Meng; Wenjing Liu; Jun Zeng; Renshuai Zhang; Yingchun Shao; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.